The global proteomics market is expected to
reach over USD 24.8 billion by 2024 according to a new report by Grand View
Research, Inc. The introduction of technology-enabled proteomics products is
one of the high-impact rendering drivers for the proteomics market growth.
These products find extensive applications in drug discovery, diagnostic
services, and many other research areas. The increasing market penetration of these
technologies, such as ESI-LC-MS (electrospray ionization liquid chromatography
mass spectrometry), is expected to serve as a driver of this market.
Proteomics has become a powerful tool for
treating various diseases such as diabetes, fatty liver, obesity, and deadly
cancers. It is difficult to cure these diseases as body responses vary from
person to person; to overcome this problem, researcher from Ecole Polytechnique
Fédérale de Lausanne and ETH Zurich in Switzerland developed method to define
metabolic differences between individuals. This is expected to drive the demand
for proteomics over the forecast period.
The presence of organizations such as the
Human Proteome Organization promotes the development of new techniques,
technologies, and training pertaining to the field of proteomics. This is
expected to propel the market growth over the forecast period.
Access
Research Report of Proteomics
Market@ www.grandviewresearch.com/industry-analysis/proteomics-market
Further Key Findings From the Study Suggest:
· The reagents segment dominated the product
segment in 2015 and is expected to witness a lucrative growth with a CAGR of
over 8.5%. Extensive usage of reagents for R&D activities and the
introduction of novel biomarker-specific kits, such as Pro2PSA biomarker for
prostate cancer and CA27.29biomarkers for breast cancer, are the factors
responsible for its large market share.
· The instruments segment is anticipated to
show a significant growth over the forecast period. The major factor
responsible for the growth is the rising demand for user-friendly,
cost-effective, rapid, and accurate devices
· In 2014, the protein microarray segment
occupied over45% of the market share of the proteomics market, owing to the
high usage rates of this technology. Microarray technology has the ability to
track the protein interactions and performs chromatography and
2-Delectrophoresis in a comparatively lesser time.
· The spectroscopy segment is one of the
fastest growing segments of proteomics market. The introduction of novel
technologies such as Orbitrap Mass spectroscopy and the increasing demand for
rapid and accurate devices for complete analysis of proteins are the factors
responsible for its fastest growth.
· North America held the largest share of
over 40% in 2015. The presence of favorable government initiatives and the
growing adoption of personalized medicines are the key factors that can be
attributed to the major revenue share in the market.
· Asia Pacific is expected to be the fastest
growing with a share of over 12% in 2015.The growing prevalence of chronic
diseases in the developing countries is a key factor responsible for the
fastest growth in Asia Pacific.
Grand View Research has segmented the
proteomics market on the basis of product, technology, application, and region:
Proteomics Market Product Outlook, by
Revenue (USD Million, 2013 & 2024)
·
Instruments
·
Reagents
·
Services
Proteomics Market Technology Outlook, by
Revenue (USD Million, 2013 & 2024)
·
Microarray Instruments
·
X-Ray Crystallography
·
Spectroscopy
·
Chromatography
·
Protein Fractionation Systems
·
Electrophoresis
·
Surface Plasma Resonance Systems
Proteomics Market Application Outlook, by
Revenue (USD Million, 2013 & 2024)
·
Drug Discovery
·
Clinical Diagnosis
·
Others
Proteomics Market Regional Outlook, by
Revenue (USD Million, 2015 & 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
·
MEA
o South
Africa
Access
Press Release of Proteomics Market@ www.grandviewresearch.com/press-release/global-proteomics-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment